Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957892 · ClinicalTrials.gov registry record
Effects of Infant Formula Composition on Infant Feeding Behaviors
A clinical trial, sponsored by Monell Chemical Senses Center.
- Completed
- Registry status
- 55
- Enrollment target
NCT00957892: Completed study, sponsored by Monell Chemical Senses Center.
NCT00957892 is a clinical trial that has completed, run by Monell Chemical Senses Center. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957892 has completed, sponsored by Monell Chemical Senses Center.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
There is a paucity of information on whether and how the composition of formulas fed to infants influences their short-term feeding behaviors during the first few months of life. The purpose of this study is to investigate whether the composition of infant formula affects infants' feeding behaviors, in particular, how much formula is consumed within a given feed (i.e., measure of satiation) and how much time elapses after the feed until the infant exhibits signs of hunger (i.e., measure of satiety). The investigators will also examine the relationship between the composition of infant formula consumed and infant temperature, activity, sleep, and mothers' perceptions of infants' intake and regulatory behaviors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-03 |
What the finished NCT00957892 record still lists
NCT00957892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00957892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00957892 about?
NCT00957892 is a clinical study titled "Effects of Infant Formula Composition on Infant Feeding Behaviors". There is a paucity of information on whether and how the composition of formulas fed to infants influences their short-term feeding behaviors during the first few months of life. The purpose of this study is to investigate whether the composition of infant formula affects infants' feeding behaviors,...
What is the current status of trial NCT00957892?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2009-05. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00957892?
This trial is sponsored by Monell Chemical Senses Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia